Effectiveness of a Workplace "Sit Less and Move More" Web-based Program in Spanish Office Employees (Walk@WorkSpain) (W@WS)

Effectiveness of a Workplace "Sit Less and Move More" Web-based Program (Walk@WorkSpain) on Occupational Sedentary Behavior, Habitual Physical Activity, Physical Risk Factors for Chronic Disease and Efficiency-related Outcomes in Spanish Office Employees

This study assesses the short and mid-term impacts of a workplace web-based intervention (Walk@WorkSpain, W@WS) on self-reported occupational sitting time, step counts, activity-related energy expenditure, physical risk factors for chronic disease and efficiency-related outcomes in Spanish office employees. Half of participants had access to the W@WS website program while the other half was asked to maintain habitual behaviour.

Study Overview

Detailed Description

Rising numbers of people have to sit for long hours every day especially for work and transport (3401184). This sedentary pattern that has been detrimentally associated with obesity and cardiovascular disease markers (4604082). However, replacing as little as 10 minutes of sedentary time with the same amount of light or moderate physical activity is associated with substantial health benefits (i.e. reduction of the metabolic syndrome) (26635358).

Because eighty percent of adults in developed countries spend one third of their working day doing sedentary, desk-based tasks (24603203) -representing a high exposure to this established health risk- displacing occupational sitting with physical activity may be a feasible option for improving office employees´ health and therefore public health (26984326).

In this context, there is a need to develop and evaluate translational research, based on theoretically-derived strategies, that can be successfully embedded into workplaces (26984326).

Study Type

Interventional

Enrollment (Actual)

264

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Barcelona, Spain, 08022
        • University Ramon Llull
    • Barcelona
      • Vic, Barcelona, Spain, 08500
        • University of Vic-Central University of Catalonia
    • Galicia
      • Pontevedra, Galicia, Spain, 36005
        • University of Vigo
    • Vasque Country
      • Vitoria, Vasque Country, Spain, 01007
        • Vasque Country University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Office employees (university administrative and academic staff) with low and moderate physical activity levels (0 to 3,000 MET·min·wk-1 according to the International Physical Activity Questionnaire)

Exclusion Criteria:

  • Highly active office employees (>3,000 MET·min·wk-1 according to the International Physical Activity Questionnaire)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention group
Had access to the W@WS website program during 19 weeks.
W@WS encourages office employees to progressively 'sit less and move more' during workdays over 19 weeks. During the first 8 weeks (ramping phase), tips are provided every two weeks to break occupational sitting time through incidental movement during work tasks, introduce short walks (5-10 minutes) during morning/afternoon work breaks and/or commuting time, introduce longer walks at lunchtime and achieve at least 10,000 daily steps as well as increase walking intensity. During weeks 9 to 19, W@WS provides automated guidance with periodic emails encouraging behaviors achieved in the previous phase. Ecological support strategies such as logging daily step counts into a personal account and receiving visual feedback on the achievement of goals are also provided
Other Names:
  • Walk@WorkSpain
  • W@WS
Active Comparator: Active comparison group
Maintained habitual behavior.
The Active Comparison group maintained habitual behavior. The A-CG was given a pedometer and a paper diary to register daily step counts and self-reported sitting time throughout the intervention.
Other Names:
  • A-CG

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline occupational sitting time (minutes/day) at post-intervention (19 weeks) and two months follow-up.
Time Frame: Baseline,19 weeks, two months follow-up
A paper diary log assessed self-reported occupational sitting time.
Baseline,19 weeks, two months follow-up
Change from baseline step counts (steps/day) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline,19 weeks, two months follow-up
A pedometer (Yamax 200) assessed daily step counts
Baseline,19 weeks, two months follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change from baseline waist circumference (cms) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline,19 weeks, two months follow-up
A flexible steel tape (Seca 203) assessed waist circumference
Baseline,19 weeks, two months follow-up
Change from baseline body mass index (kgs/m-2) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline, 19 weeks, two months follow-up
An electronic scale (Seca 899/217) assessed body weight and height to calculate BMI.
Baseline, 19 weeks, two months follow-up
Change from baseline blood pressure (mmHg) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline, 19 weeks, two months follow-up
A digital automatic blood pressure monitor (Omron M7) assessed blood pressure.
Baseline, 19 weeks, two months follow-up
Change from baseline mental well-being (WEMWBS scale scores) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline, 19 weeks, two months follow-up
The Warwick-Edinburg Mental Well-Being Scale (WEMWBS) assessed mental well-being
Baseline, 19 weeks, two months follow-up
Change from baseline presenteeism (WLQ scores) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline, 19 weeks, two months follow-up
The Work Limitations Questionnaire (WLQ) assessed presenteeism.
Baseline, 19 weeks, two months follow-up
Change from baseline % work productivity loss (WLQ index score) at post-intervention (19 weeks) and two months follow-up
Time Frame: Baseline, 19 weeks, two months follow-up
The Work Limitations Questionnaire (WLQ) assessed % of work productivity loss
Baseline, 19 weeks, two months follow-up
Change from baseline activity-related energy expenditure (METs-min/week) at post-intervention (19 weeks) and two months follow-up.
Time Frame: Baseline, 19 weeks, two months follow-up
The International Physical Activity Questionnaire (IPAQ) short form assessed activity-related energy expenditure
Baseline, 19 weeks, two months follow-up

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Anna Puig-Ribera, Exercise and Health Sciences, University of Vic - Central University of Catalonia

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2010

Primary Completion (Actual)

June 1, 2011

Study Completion (Actual)

June 1, 2011

Study Registration Dates

First Submitted

November 3, 2016

First Submitted That Met QC Criteria

November 7, 2016

First Posted (Estimate)

November 10, 2016

Study Record Updates

Last Update Posted (Estimate)

November 10, 2016

Last Update Submitted That Met QC Criteria

November 7, 2016

Last Verified

November 1, 2016

More Information

Terms related to this study

Other Study ID Numbers

  • OR0431+D3009
  • DEP2009-11472 (Other Grant/Funding Number: Ministerio de Ciencia e Innovación)

Plan for Individual participant data (IPD)

Study Data/Documents

  1. Clinical Study Report
    Information identifier: 4382156
  2. Clinical Study Report
    Information identifier: 4323230
  3. Clinical Study Report
    Information identifier: 4266209

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe